Impact of Repeated Cycles of EGF Bispecific Angiotoxin (eBAT) Administered at a Reduced Interval from Doxorubicin Chemotherapy in Dogs with Splenic Hemangiosarcoma

We previously reported that eBAT, an EGF-targeted angiotoxin, was safe and improved overall survival for dogs with splenic hemangiosarcoma when added to the standard of care in a single cycle of three administrations in the minimal residual disease setting. Our objective for the SRCBST-2 trial was t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Vet Comp Oncol
Main Authors: Borgatti, Antonella, Fieberg, Ann, Winter, Amber L., Stuebner, Kathleen, Taras, Elizabeth, Todhunter, Deborah, Masyr, Alison, Rendhal, Aaron, Vallera, Daniel A., Koopmeiners, Joseph S., Modiano, Jaime F.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7501152/
https://ncbi.nlm.nih.gov/pubmed/32187827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12590
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker